A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT05949606 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: SI-B001
DRUG: SI-B003

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.